Cargando…

Rosiglitazone and a β(3)-Adrenoceptor Agonist Are Both Required for Functional Browning of White Adipocytes in Culture

The recruitment of brite (or beige) adipocytes has been advocated as a means to combat obesity, due to their ability to phenotypically resemble brown adipocytes (BA). Lineage studies indicate that brite adipocytes are formed by differentiation of precursor cells or by direct conversion of existing w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Merlin, Jon, Sato, Masaaki, Chia, Ling Yeong, Fahey, Richard, Pakzad, Mohsen, Nowell, Cameron J., Summers, Roger J., Bengtsson, Tore, Evans, Bronwyn A., Hutchinson, Dana S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992408/ https://www.ncbi.nlm.nih.gov/pubmed/29910772 http://dx.doi.org/10.3389/fendo.2018.00249

Ejemplares similares

The metabolic effects of mirabegron are mediated primarily by β(3)‐adrenoceptors
por: Dehvari, Nodi, et al.
Publicado: (2020)

Acute β-adrenoceptor mediated glucose clearance in brown adipose tissue; a distinct pathway independent of functional insulin signaling
por: Olsen, Jessica M., et al.
Publicado: (2019)

Rosiglitazone is a superior bronchodilator compared to chloroquine and β-adrenoceptor agonists in mouse lung slices
por: Donovan, Chantal, et al.
Publicado: (2014)

Rosiglitazone Enhances Browning Adipocytes in Association with MAPK and PI3-K Pathways During the Differentiation of Telomerase-Transformed Mesenchymal Stromal Cells into Adipocytes
por: Fayyad, Abeer Maher, et al.
Publicado: (2019)

Myosin 1c: A novel regulator of glucose uptake in brown adipocytes
por: Åslund, Alice, et al.
Publicado: (2021)

Real-time monitoring of cAMP in brown adipocytes reveals differential compartmentation of β(1) and β(3)-adrenoceptor signalling
por: Kannabiran, Sukanya Arcot, et al.
Publicado: (2020)

Both proliferation and lipogenesis of brown adipocytes contribute to postnatal brown adipose tissue growth in mice
por: Negron, Steven G., et al.
Publicado: (2020)

β(2)‐Adrenoceptor agonist activity of higenamine
por: Hudzik, Thomas J., et al.
Publicado: (2021)

Orthosteric Binding of ρ-Da1a, a Natural Peptide of Snake Venom Interacting Selectively with the α(1A)-Adrenoceptor
por: Maïga, Arhamatoulaye, et al.
Publicado: (2013)

Glucose uptake in brown fat cells is dependent on mTOR complex 2–promoted GLUT1 translocation
por: Olsen, Jessica M., et al.
Publicado: (2014)

Mitochondria in White, Brown, and Beige Adipocytes
por: Cedikova, Miroslava, et al.
Publicado: (2016)

Alpha-2 adrenoceptor agonists and sepsis: improved survival?
por: Quintin, Luc
Publicado: (2010)

Paradoxical bronchoconstriction caused by β(2)-adrenoceptor agonists
por: Ayed, Khadija, et al.
Publicado: (2020)

Agonist Antibody Converts Stem Cells into Migrating Brown Adipocyte-Like Cells in Heart
por: Han, Kyung Ho, et al.
Publicado: (2020)

Anti-Inflammatory Effects of Rosiglitazone in Obesity-Impaired Wound Healing Depend on Adipocyte Differentiation
por: Siebert, Anna, et al.
Publicado: (2016)

Transcriptomic profiling of the telomerase transformed Mesenchymal stromal cells derived adipocytes in response to rosiglitazone
por: Al-Ali, Moza Mohamed, et al.
Publicado: (2022)

Structure and Function of an Irreversible Agonist-β(2) Adrenoceptor complex
por: Rosenbaum, Daniel M., et al.
Publicado: (2011)

Functional desensitization of the β(2) adrenoceptor is not dependent on agonist efficacy
por: Rosethorne, Elizabeth M, et al.
Publicado: (2015)

A Selective Pharmacophore Model for β(2)-Adrenoceptor Agonists
por: Xing, Rui-Juan, et al.
Publicado: (2009)

On the Site and Mechanism of Action of β(3)-Adrenoceptor Agonists in the Bladder
por: Andersson, Karl Erik
Publicado: (2017)

β-Adrenoceptor Signaling Networks in Adipocytes for Recruiting Stored Fat and Energy Expenditure
por: Collins, Sheila
Publicado: (2012)

The selectivity of α‐adrenoceptor agonists for the human α1A, α1B, and α1D‐adrenoceptors
por: Proudman, Richard G. W., et al.
Publicado: (2021)

Brown adipogenic potential of brown adipocytes and peri-renal adipocytes from human embryo
por: Wu, Nan-Nan, et al.
Publicado: (2016)

Loading and firing the brown adipocyte
por: Hankir, Mohammed K.
Publicado: (2017)

The PPARγ Agonist Rosiglitazone Impairs Colonic Inflammation in Mice with Experimental Colitis
por: Ramakers, Julian D., et al.
Publicado: (2007)

The PPARγ Agonist Rosiglitazone Enhances the Radiosensitivity of Human Pancreatic Cancer Cells
por: Wang, Zhenyu, et al.
Publicado: (2020)

The signaling and selectivity of α‐adrenoceptor agonists for the human α2A, α2B and α2C‐adrenoceptors and comparison with human α1 and β‐adrenoceptors
por: Proudman, Richard G. W., et al.
Publicado: (2022)

Anti-diabetic rosiglitazone remodels the adipocyte transcriptome by redistributing transcription to PPARγ-driven enhancers
por: Step, Sonia E., et al.
Publicado: (2014)

Rosiglitazone drives cavin-2/SDPR expression in adipocytes in a CEBPα-dependent manner
por: Hansson, Björn, et al.
Publicado: (2017)

Long-acting β-adrenoceptor agonists in the management of COPD: focus on indacaterol
por: Beier, Jutta, et al.
Publicado: (2011)

Beta3-Adrenoceptor Agonists: Possible Role in the Treatment of Overactive Bladder
por: Igawa, Yasuhiko, et al.
Publicado: (2010)

Altered uterine contractility in response to β-adrenoceptor agonists in ovarian cancer
por: Modzelewska, Beata, et al.
Publicado: (2016)

Alpha(2)‐adrenoceptor agonists inhibit form‐deprivation myopia in the chick
por: Carr, Brittany J, et al.
Publicado: (2019)

A Clinician’s Perspective on the Mechanism of β(3)-Adrenoceptor Agonists in the Bladder
por: Lee, Tack
Publicado: (2017)

Treatment with a β-2-adrenoceptor agonist stimulates glucose uptake in skeletal muscle and improves glucose homeostasis, insulin resistance and hepatic steatosis in mice with diet-induced obesity
por: Kalinovich, Anastasia, et al.
Publicado: (2020)

Expression of GPR43 in Brown Adipogenesis Is Enhanced by Rosiglitazone and Controlled by PPARγ/RXR Heterodimerization
por: Hu, Jiamiao, et al.
Publicado: (2018)

The effects of PPARγ agonist rosiglitazone on neointimal hyperplasia in rabbit carotid anastomosis model
por: Guzeloglu, Mehmet, et al.
Publicado: (2012)

Antitumor action of the peroxisome proliferator-activated receptor-γ agonist rosiglitazone in hepatocellular carcinoma
por: BO, QI-FU, et al.
Publicado: (2015)

Leukemia and rosiglitazone
por: Yavasoglu, Irfan, et al.
Publicado: (2016)

The Therapeutic Potential of Brown Adipocytes in Humans
por: Porter, Craig, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_an0sg4tpelnc2ell82e2b0vttn